# Overture Life

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/overture-life

- Industry: Biotechnology
- Headquarters: Coral Gables, US
- Website: www.overture.life/
- Total disclosed funding: $15M
- Latest round: Series B (May 25, 2021)
- Investors on record: 4

## About

Founded in 2017 based in  Palo Alto, US, focuses on revolutionizing assisted reproductive technology by developing advanced automated solutions for fertility treatment, enhancing outcomes for patients seeking support in reproductive health. Overture Life specializes in assisted reproductive technology. Overture Life specializes in the development of innovative solutions aimed at transforming assisted reproductive technology (ART) to enhance fertility treatment outcomes. The company's core offerings include advanced automated systems designed to streamline and improve the in vitro fertilization (IVF) process, thereby addressing barriers that commonly hinder ART effectiveness. Among their flagship products are DaVitri, m|z, and ICSI.A, each engineered to optimize various stages of fertility treatment by integrating technology that minimizes manual intervention. These products cater to a diverse client base, including fertility clinics, healthcare providers, and reproductive specialists across various geographical markets, specifically in North America, Europe, and parts of Asia. By focusing on automation and technology, Overture Life aims to deliver improvements in treatment success rates while simultaneously reducing costs for patients seeking fertility assistance.The revenue structure of Overture Life revolves around the direct sale and implementation of its specialized fertility technology products to healthcare providers and fertility clinics. Transactions typically involve bulk procurement agreements where clinics purchase systems like DaVitri, m|z, and ICSI.A as part of their ART services. The company employs a B2B model, focusing on establishing long-term partnerships with reproductive health facilities, which may include training and technical support as part of the service package. Pricing structures are tailored to the specific needs of each clinic based on the volume of products ordered and the scope of services provided. In November 2025, Overture Life raised EUR 20 million in venture debt?funding?from new investor?European Investment Bank. The company will use the funding to automate assisted reproductive processes, scale manufacturing, conduct clinical trials, and commercialize fertility solutions in Europe.

## Funding rounds

- Series B, May 25, 2021, $15M — Khosla Ventures, GV, Felicis Ventures, Octopus Investments

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B
- GV (https://capitalatlas.ai/funds/gv) — Series B
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series B
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series B